USRDS Coordinating Center
914 South 8th Street
Suite S-206
Minneapolis, MN 55404
(612) 347-7776
1-888-99USRDS
2007    2006    2005    2004    2003     2002    2001    2000 
2004

ASN 2004 USRDS Abstracts

 
Preventive Health Care Measures Are Decreased in Pediatric Compared to Adult Chronic Dialysis Patients.
   
Characteristics of the ESRD U.S. Nursing Home Population Using the Minimum Data Set.
   
L-Carnitine Use in U.S. Dialysis Patients before 2003 National Coverage Decision.
   
L-Carnitine Treatment and Hemoglobin (Hb) and Erythropoietin (EPO) Outcomes in Dialysis Patients.
   
Pneumococcal Vaccination Rates as Indicated by Medicare Claims among End-Stage Renal Disease (ESRD) Patients.
   
Evidence of Herd Immunity to Invasive Pneumococcal Disease Following Introduction of Pneumococcal Conjugate Vaccine.
   
Disruption in Pneumococcal Vaccine Administration during Influenza Vaccine Shortage.
   
Pregnancy, Antepartum Complication, and Outcome Rates in the Dialysis and Renal Transplant Populations.
   
Nephrology Referral and Outcome after CKD Diagnosis in the US Medicare Population.
   
Lifetime Medical Cost of ESRD Dialysis Patients.
   
Renal Transplant Recipients with Good Function Post-Transplant Are More Likely To Die Than Return to Dialysis.
   
Racial and Ethnic Differences in Developing End-Stage Renal Disease.
   
Expenditures Associated with Acute Renal Failure in Medicare Beneficiaries.
   
Clinical Epidemiology of Pneumonia in Hemodialysis Patients.
   
Calcium, Phosphorus, Parathyroid Hormone, and Cardiovascular Disease in Hemodialysis Patients. The USRDS Waves 1, 3, and 4 Study.
   
Atherosclerotic Renovascular Disease (ARVD) in the US Medicare Population: Incidence, Risk Factors and Prognosis.
   
Revascularization for Atherosclerotic Renovascular Disease (ARVD) in the US Medicare Population.
   
Trends in Incidence Rates for ESRD Secondary to Diabetes Mellitus (DM): The Potential Impact of Clinical Interventions to Slow CKD Progression.